CPD (Fenwal, Inc.)
Welcome to the PulseAid listing for the CPD drug offered from Fenwal, Inc.. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fenwal, Inc. |
NON-PROPRIETARY NAME: | Anticoagulant Citrate Phosphate Dextrose (CPD) |
SUBSTANCE NAME: | TRISODIUM CITRATE DIHYDRATE; DEXTROSE MONOHYDRATE; ANHYDROUS CITRIC ACID; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2007-03-01 |
END MARKETING DATE: | 0000-00-00 |
CPD HUMAN PRESCRIPTION DRUG Details:
Item Description | CPD from Fenwal, Inc. |
LABELER NAME: | Fenwal, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1.66; 1.61; 188; 140(g/63mL; g/63mL; mg/63mL; mg/63mL) |
START MARKETING DATE: | 2007-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0942-9206_78fada3f-c891-4ffa-b78b-3cb9b83595ca |
PRODUCT NDC: | 0942-9206 |
APPLICATION NUMBER: | BN170401 |
Other TRISODIUM CITRATE DIHYDRATE; DEXTROSE MONOHYDRATE; ANHYDROUS CITRIC ACID; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Pharmaceutical Manufacturers / Labelers: